Puymirat E, Douard H, Roudaut R
Service de cardiologie, hôpital Haut-Lévêque, 1, avenue Magellan, 33604 Pessac, France.
Rev Med Interne. 2008 Sep;29(9):741-3. doi: 10.1016/j.revmed.2008.06.019. Epub 2008 Aug 8.
Antimalarial agents are routinely used in the management of connective tissues diseases and various skin disorders. Ophthalmologic, neurological and digestive side effects of antimalarial agents are well known. However, cardiac toxicity is uncommon. We report a 49-year-old patient, treated with chloroquine for 21 years for a systemic lupus erythematosus and a discoid lupus, who presented a complete atrioventricular block that required implantation of a cardiac pacemaker in emergency. This patient did not have significant cardiovascular past medical history. Investigations excluded known causes of atrioventricular block and chloroquine toxicity was diagnosed. This case report illustrates the cardiotoxicity of synthetic antimalarial agents. A regular cardiovascular monitoring (especially with electrocardiogram) could be useful in patients receiving long-term treatment with antimalarial agents.
抗疟药常用于结缔组织疾病和各种皮肤疾病的治疗。抗疟药的眼科、神经科和消化系统副作用已广为人知。然而,心脏毒性并不常见。我们报告一名49岁患者,因系统性红斑狼疮和盘状红斑狼疮接受氯喹治疗21年,出现完全性房室传导阻滞,需紧急植入心脏起搏器。该患者既往无明显心血管病史。检查排除了已知的房室传导阻滞病因,诊断为氯喹毒性。本病例报告说明了合成抗疟药的心脏毒性。对于接受抗疟药长期治疗的患者,定期进行心血管监测(尤其是心电图监测)可能会有帮助。